In the tumor context, the aberrant metabolism coupled with the typical hypoxic conditions leads to proangiogenic factor overexpression, including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and matrix metalloproteases (MMPs) [66,67]. This evidence concerns the gene VEGFA and neoplasm.